Skip to Main Content

Paper Details

PD-1 combination therapy with IL-2 modifies CD8<sup>+</sup> T cell exhaustion program.
Nature
98
2022
-, 1TCF1, CD122, CD132, CD25, CD8, CD8 T cell, CD8 T cells, IL-2, PD-, PD-1, PD-1TCF1, acute viral infection, cancer, chronic lymphocytic choriomeningitis virus infection, effector CD8 T cells, exhausted CD8 T cells, high-affinity IL-, human, patients, stem, stem-like CD8 T cells, virus-specific effector CD8 T cells
Author NameAffiliation
Andreas WielandEmory University School of Medicine
Andreas WielandThe Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center
Andreas WielandThe Ohio State University College of Medicine
Andreas WielandEmory University School of Medicine
James L RossEmory University School of Medicine
James L RossEmory University School of Medicine
William J GreenleafStanford University School of Medicine
William J GreenleafStanford University School of Medicine
Rafi AhmedEmory University School of Medicine
Rafi AhmedEmory University School of Medicine
Rafi AhmedWinship Cancer Institute, Emory University
  • 1 - 11

Datasets

Release 1.2